Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.

Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J Clin Invest (2005) 1.92

Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A (2003) 1.74

SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions. Semin Immunopathol (2010) 1.23

Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. EMBO J (2001) 1.10

CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. J Biol Chem (2010) 0.97

Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters. Immunogenetics (2006) 0.92

CD84 negatively regulates IgE high-affinity receptor signaling in human mast cells. J Immunol (2011) 0.88

Ly9 (CD229) Cell-Surface Receptor is Crucial for the Development of Spontaneous Autoantibody Production to Nuclear Antigens. Front Immunol (2013) 0.84

Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors. J Biol Chem (2012) 0.84

Immune cell inhibition by SLAMF7 is mediated by a mechanism requiring src kinases, CD45, and SHIP-1 that is defective in multiple myeloma cells. Mol Cell Biol (2014) 0.82

Fine specificity and molecular competition in SLAM family receptor signalling. PLoS One (2014) 0.81

Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription. Immunogenetics (2003) 0.79

A polymorphism in a phosphotyrosine signalling motif of CD229 (Ly9, SLAMF3) alters SH2 domain binding and T-cell activation. Immunology (2015) 0.78

Responses to Microbial Challenges by SLAMF Receptors. Front Immunol (2016) 0.77

Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses. J Immunol (2015) 0.76

The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival. J Immunol (2015) 0.75

50-S ribosomal proteins. Peptide studies on two acidic proteins, A 1 and A 2 , isolated from 50-S ribosomes of Escherichia coli. Eur J Biochem (1972) 16.92

50-S ribosomal proteins. Purification and partial characterization of two acidic proteins, A 1 and A 2, isolated from 50-S ribosomes of Escherichia coli. Eur J Biochem (1972) 16.79

Changes in forest biomass carbon storage in China between 1949 and 1998. Science (2001) 7.39

Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A (1991) 5.78

The role of the T3/antigen receptor complex in T-cell activation. Annu Rev Immunol (1986) 5.67

The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol (1988) 5.10

Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature (1998) 4.97

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature (1998) 4.47

Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet (1998) 3.89

Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J (1993) 3.58

Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol Cell (1999) 3.58

Sequence and expression of transcripts of the human T-cell receptor beta-chain genes. Nature (1985) 3.53

Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature (1989) 3.49

The selectins: vascular adhesion molecules. FASEB J (1995) 3.45

Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med (1995) 3.40

Isolation of cDNA clones encoding the 20K T3 glycoprotein of human T-cell receptor complex. Nature (1985) 3.34

A T3-like protein complex associated with the antigen receptor on murine T cells. Nature (1986) 3.22

Cripto is required for correct orientation of the anterior-posterior axis in the mouse embryo. Nature (1998) 3.16

Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM). Ann Oncol (2010) 3.00

E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A (1995) 2.99

An open label study of the effects of rituximab in neuromyelitis optica. Neurology (2005) 2.99

SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol (2001) 2.95

Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. Hybridoma (1982) 2.92

The gene encoding the epsilon subunit of the T3/T-cell receptor complex maps to chromosome 11 in humans and to chromosome 9 in mice. Proc Natl Acad Sci U S A (1987) 2.91

Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol (1995) 2.90

Characterization of a human B cell-specific antigen (B2) distinct from B1. J Immunol (1981) 2.86

Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer. Nature (1985) 2.84

Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex. Nature (1986) 2.76

Tay-sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay. N Engl J Med (1970) 2.75

Structure of HLA antigens: amino-acid and carbohydrate compositions and NH2-terminal sequences of four antigen preparations. Proc Natl Acad Sci U S A (1976) 2.71

Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen. J Immunol (1985) 2.70

Stimulation of the T3-T cell receptor complex induces a membrane-potential-sensitive calcium influx. Cell (1985) 2.69

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)). Ann Rheum Dis (2010) 2.68

Monoallelic expression of the interleukin-2 locus. Science (1998) 2.58

Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res (1999) 2.54

Conjugation of Nedd8 to CUL1 enhances the ability of the ROC1-CUL1 complex to promote ubiquitin polymerization. J Biol Chem (2000) 2.53

Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52

T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med (1998) 2.50

Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo1 deficiency. Effects of cell activation on Mo1/LFA-1 surface expression in normal and deficient leukocytes. J Clin Invest (1984) 2.46

Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J Biol Chem (1994) 2.46

Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus. Proc Natl Acad Sci U S A (1978) 2.41

Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes. Nature (1981) 2.39

Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. J Immunol (1983) 2.37

Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet (2001) 2.34

Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc Natl Acad Sci U S A (2001) 2.29

Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J Virol (1994) 2.29

CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today (1994) 2.25

ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene (2010) 2.25

A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25

Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol (2001) 2.20

A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol (1997) 2.13

Severe colitis in mice with aberrant thymic selection. Immunity (1995) 2.11

Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control (2001) 2.10

A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci U S A (1994) 2.10

Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol (2008) 2.06

HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin. Oncogene (1999) 2.05

Biochemical analysis of human T lymphocyte differentiation antigens T4 and T5. Science (1980) 2.05

The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E. J Mol Biol (2001) 2.05

Paracetamol metabolism following overdosage: application of high performance liquid chromatography. J Pharm Pharmacol (1977) 2.01

Expression of murine CD1 on gastrointestinal epithelium. Science (1990) 2.00

Complexity of the human T lymphocyte-specific cell surface antigen T3. J Immunol (1982) 1.98

The T3 complex on human thymus-derived lymphocytes contains two different subunits of 20 kDa. Eur J Immunol (1983) 1.97

Kainate receptor-mediated heterosynaptic facilitation in the amygdala. Nat Neurosci (2001) 1.96

The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. J Biol Chem (1983) 1.94

Characterization of the two heavy chains of the T3 complex on the surface of human T lymphocytes. J Biol Chem (1984) 1.93

Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10. Cell (1981) 1.92

Isolation and characterization of a cDNA clone encoding the murine homologue of the human 20K T3/T-cell receptor glycoprotein. Nature (1985) 1.92

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis (2010) 1.90

A T cell-specific enhancer is located in a DNase I-hypersensitive area at the 3' end of the CD3-delta gene. EMBO J (1988) 1.90

Purification and structural characterisation of human HLA-linked B-cell antigens. Nature (1977) 1.83

Energy landscape of streptavidin-biotin complexes measured by atomic force microscopy. Biochemistry (2000) 1.81

Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines. Hybridoma (1983) 1.79

An immunodeficiency characterized by defective signal transduction in T lymphocytes. N Engl J Med (1989) 1.79

Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet (2001) 1.78

Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem (2001) 1.77

Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1. Cell (1986) 1.77

Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J Immunol (1991) 1.75

Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology (2000) 1.75

Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet (1998) 1.75

The use of the GlideScope for tracheal intubation in patients with ankylosing spondylitis. Br J Anaesth (2006) 1.74

Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci (2001) 1.73

HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur J Immunol (1984) 1.73

An enhancer located in a CpG-island 3' to the TCR/CD3-epsilon gene confers T lymphocyte-specificity to its promoter. EMBO J (1989) 1.72

Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature (1995) 1.71

Assignment of the gene coding for the T3-delta subunit of the T3-T-cell receptor complex to the long arm of human chromosome 11 and to mouse chromosome 9. Proc Natl Acad Sci U S A (1985) 1.70

Characterization of T cell surface glycoproteins T 1 and T 3 present on all human peripheral T lymphocytes and functionally mature thymocytes. Eur J Immunol (1981) 1.70

Assembly of the human T cell receptor-CD3 complex takes place in the endoplasmic reticulum and involves intermediary complexes between the CD3-gamma.delta.epsilon core and single T cell receptor alpha or beta chains. J Biol Chem (1988) 1.68

Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem (1997) 1.68

The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation. Mol Cell Biol (2000) 1.67

Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology (1998) 1.65

Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA-1, Mo-1 and p150,95. Eur J Immunol (1985) 1.64

Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets. Development (2000) 1.62

Midazolam vs ondansetron for preventing postoperative nausea and vomiting: a randomised controlled trial. Anaesthesia (2007) 1.60

T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol (1993) 1.59

Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol (1998) 1.59

[Pandemic influenza A in the ICU: experience in Spain and Latin America. GETGAG/SEMICYUC/(Spanish Working Group on Severe Pandemic Influenza A/SEMICYUC)]. Med Intensiva (2010) 1.58

Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood (1995) 1.58